Physician profile
Austin E Beard
NPI 1972033348
$754.67
in general payments reported to CMS, 2019-2025
14 companies · $96.98 in 2025
The $96.98 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $19.40 · 2021: $17.82 · 2022: $230 · 2023: $214 · 2024: $42.07 · 2025: $96.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255 · Education: $97.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.67 |
| Education | $97.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Notal Vision, INC. | $158.68 | 2022 | |
| Alcon Vision LLC | $157.32 | 2019-2025 | Rocklatan, Precision7, Total30 |
| Mallinckrodt Hospital Products INC. | $131.71 | 2022-2023 | Acthar |
| Oyster Point Pharma, INC. | $85.53 | 2022-2024 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $34.43 | 2023 | |
| Coopervision INC. | $30.88 | 2022-2023 | Myday Contact Lens |
| Tarsus Pharmaceuticals, INC. | $28.56 | 2025 | Xdemvy |
| Thea Pharma INC. | $25.03 | 2025 | Iyuzeh |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.82 | 2021 | |
| Shire North American Group INC | $17.21 | 2019 | |
| Biotissue Holdings INC. | $16.94 | 2019 | |
| Allergan, INC. | $16.46 | 2019 | |
| Lkc Technologies, INC. | $14.70 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Beard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.